Table 3.
Correlations | WHO 4 | WHO 5 | WHO 6 | WHO 7 | WHO 8 |
---|---|---|---|---|---|
Anthropometric Data | |||||
Age (years) | 0.336 ** | 0.182 ** | 0.19 ** | 0.093 | 0.324 ** |
BMI (kg/m2) | 0.187 ** | 0.107 | 0.154 ** | 0.103 | 0.067 |
SBP (mmHg) | 0.112 | −0.017 | 0.052 * | 0.038 | 0.097 |
DBP (mmHg) | −0.07 | −0.094 | −0.075 | −0.143 * | −0.112 |
Background and Comorbidities | |||||
Exercise | −0.308 ** | −0.194 ** | −0.287 ** | −0.22 ** | −0.275 ** |
MS | 0.107 | 0.018 | 0.031 | 0.041 | 0.232 ** |
T2DM | 0.191 ** | 0.125 * | 0.148 * | 0.021 | 0.212 ** |
Dyslipidemia | 0.11 | 0.075 | 0.069 | 0.143 * | 0.176 ** |
Hypertension | 0.286 ** | 0.062 | 0.1 | 0.091 | 0.257 ** |
CVD | 0.069 | −0.046 | −0.048 | 0.002 | 0.157 ** |
Respiratory diseases | −0.035 | 0.019 | −0.003 | −0.082 | 0.123 * |
Cancer | 0.103 | 0.126* | 0.085 | 0.063 | 0.279 ** |
COVID-19 Treatment | |||||
Hydroxychloroquine | 0.664 ** | 0.284 ** | 0.496 ** | 0.336 ** | 0.218 ** |
Azithromycin | 0.217 ** | 0.024 | 0.066 | −0.04 | 0.049 |
Lopinavir−ritonavir | 0.569 ** | 0.293 ** | 0.462 ** | 0.372 ** | 0.107 |
Tocilizumab | 0.146 * | 0.137 * | 0.011 | 0.044 | 0.124 * |
Interferon | 0.219 ** | 0.214 ** | 0.329 ** | 0.416 ** | 0.065 |
Remdesivir | −0.038 | 0.043 | −0.133 * | −0.042 | −0.02 |
Biochemical Parameters | |||||
Leukocytes (x109/L) | 0.057 | 0.024 | 0.16 * | 0.101 | 0.087 |
Lymphocytes (%) | −0.221 ** | −0.217 ** | −0.277 ** | −0.204 ** | −0.158 * |
D-Dimer (ng/mL) | 0.246 ** | 0.119 | 0.192 * | 0.166 ** | 0.236 ** |
ESR (mm) | 0.19 * | 0.097 | 0.114 | 0.138 | 0.036 |
IL-6 (pg/mL) | 0.285 ** | 0.114 | 0.32 ** | 0.222 ** | 0.262 ** |
Ferritin (ng/mL) | 0.194 * | 0.162 * | 0.204 ** | 0.15 * | 0.082 |
CRP (mg/dL) | 0.334 ** | 0.223 ** | 0.323 ** | 0.177 ** | 0.085 |
Glucose (mg/dL) | 0.129 * | 0.038 | 0.116 | 0.106 | 0.165 ** |
Triglycerides (mg/dL) | 0.501 ** | 0.122 | 0.289 | 0.188 | 0.074 |
Creatinine (mg/dL) | 0.056 | −0.026 | 0.065 | 0.091 | 0.212 ** |
AST (U/L) | 0.104 | 0.106 | 0.137 * | 0.111 | 0.02 |
GGT (U/L) | 0.243 ** | 0.121 | 0.15 * | 0.186 ** | −0.054 |
AP (U/L) | 0.092 | 0.021 | 0.146 * | 0.117 | 0.09 |
LDH (U/L) | 0.299 ** | 0.22 ** | 0.286 ** | 0.21 ** | 0.15 * |
Troponin (ng/L) | 0.281 ** | 0.124 | 0.27 ** | 0.244 ** | 0.319 ** |
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; MS: metabolic syndrome; T2DM: type 2 diabetes mellitus; CVD: cardiovascular disease; ESR: erythrocyte sedimentation rate; IL-6: interleukin-6; CRP: c-reactive protein; AST: aspartate aminotransferase; GGT: gamma-glutamyl transferase; AP: alkaline phosphatase; LDH: lactate dehydrogenase; N: counts; WHO 4: oxygen by mask or nasal; WHO 5: non-invasive ventilation (continuous positive airway pressure [CPAP] or positive bipressure in the airways [BiPAP]) or high-flow oxygen; WHO 6: intubation with mechanical ventilation, mask with reservoir; WHO 7: mechanical ventilation or extracorporeal membrane oxygenation, support with vasopressors, or dialysis/renal replacement therapy. All correlations were expressed as Spearman rho correlation coefficient; WHO 8, death. * Significant association with a p-value < 0.05. ** Significant association with a p-value < 0.01.